Economics
Popular Cancer Pill Goes Generic, Yet Patients’ Costs Stay High
- ‘It is a very clear market failure,’ drug researcher says
- Generic versions of Gleevec still cost more than $100 a pill
Trump vs. Big Pharma: Can He Bring Drug Prices Down?
This article is for subscribers only.
Donald Jones used to pay at least $500 a month for a brand-name drug, Gleevec, that’s kept his leukemia at bay for five years.
Lately, he’s been paying almost as much for a generic version of the same pill.